Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 25

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 8
Chunk 25
---
2,288,034) 
    $(591,021) 
    $(1,697,013) 
     287%

Research
and Development Expenses

Research
and development (“R&D”) expenses were $816,697 for three months ended September 30, 2025 compared to $91,911 for three
months ended September 30, 2024, representing an increase of $724,786, or 789%. The increase in R&D expenses was
primarily driven by costs incurred under a three-year service agreement associated with product development and distribution efforts
in the Southeast Asian market. The remainder of the increase relates to heightened R&D activities, specifically the procurement of
clinical trial supplies for our Parkinson’s disease program.

General
and Administrative Expenses

General
and administrative expenses were $1,480,356 for the three months ended September 30, 2025 compared to $401,636 for the three months
ended September 30, 2024, representing an increase of $1,078,720, or 269%. The increase is due to employees receiving their full
salaries and an accrual for a bonus in the three months ended September 30, 2025 compared to the prior period. In addition, there
was an increase in legal and professional fees in the three months ended September 30, 2025 compared to the prior period as a direct
result of the Company being listed on the Nasdaq Stock Market (“Nasdaq”). Lastly, the increase in general and administrative expenses is attributed to an
increase in insurance expenses and consulting fees. Overall, this increase is a direct result of the Company expanding its
operations in the current period compared to the prior period.

Interest
Income

Interest
income was $10,212 for the three months ended September 30, 2025, compared to $23 for the three months ended September 30, 2024, representing
an increase of $10,189. The increase primarily reflects higher average cash balances and prevailing interest rates during 2025.

Interest
Expense

Interest
expense was $1,193 for the three months ended September 30, 2025, compared to $107,382 for the three months ended September 30, 2024,
representing a decrease of $106,189, or 99%. The significant decrease in the current period reflects the repayment or conversion in prior
periods of these interest-bearing obligations.

Gain
on Change in Fair Value of Derivative Liability